PHILADELPHIA, PA (December 1, 2025) – The Science Center is pleased to announce the 9th cohort of its flagship Capital Readiness Program — a five-day intensive bootcamp designed to equip medtech, digital health, and healthcare technology startups with the strategic tools, investor insight, and operational rigor necessary to execute their first institutional funding round.
Since its launch in 2023, the program has supported 80 companies who have collectively raised more than $178 million in funding. The program leverages the Science Center’s nationwide investor network, representing over $3.7 billion in venture capital, to provide deep-dive due-diligence training, one-on-one feedback sessions, real-world stress-test scenarios, and mock board meetings.
“We’re eager to convene this group of promising startups, industry-relevant investors, and world-class subject matter experts at a pivotal moment for healthcare innovation,” said Tiffany Wilson, President & CEO of the Science Center. “Startups today face not only capital competition but also complex regulatory, reimbursement, and market-access headwinds. Our Capital Readiness Program is engineered to demystify the fundraising process, elevate leadership readiness, and build resilient, high-impact companies for their next stage of growth.”
"Startups today face not only capital competition but also complex regulatory, reimbursement, and market-access headwinds. Our Capital Readiness Program is engineered to demystify the fundraising process, elevate leadership readiness, and build resilient, high-impact companies for their next stage of growth.”
Cohort 9 Companies
Aces Diagnostics (Paradise Valley, AZ)
First early and accurate diagnostic test for Lyme disease.
Ajaya Bio
(Philadelphia, PA)
Ajaya Bio engineers first-in-class bispecific antibodies that selectively eliminate the immune cells driving refractory autoimmune disease, creating the potential for finite, durable remission for patients who currently have no effective treatment options.
CorRen Medical, Inc.
(Minneapolis, MN)
CorRen is reducing preventable amputations by bringing reimbursed, specialist-grade PAD testing to primary care.
Freyya (Salt Lake City, UT)
Freyya is changing the paradigm of women's pelvic care from symptom-reactive to proactive prevention with a first-of-its kind dynamic rehabilitation system powered by advanced analytics.
Health Tequity
(Berkeley, CA)
Health Tequity is a digital care coordination platform company using digital health and AI-digital twins, integrated with clinical workflows, to deliver real-world health outcomes and improve community health.
MediCarbone, Inc.
(Tucson, AZ)
MediCarbone develops state-of-the-art, AI-personalized, minimally invasive in situ cure carbon-fiber orthopedic intramedullary implant, meticulously designed to emulate physiological bone healing and enable seamless, less invasive device removal.
Miora Health
(New York, NY)
Miora Health is transforming pregnancy care with AI-driven, microbiome-based testing that detects gestational diabetes months earlier—unlocking new pathways for prevention across maternal and metabolic health.
Tenomix (London, Ontario)
Tenomix is redefining cancer pathology through a robotics, AI, and ultrasound-based platform that automates the manual lymph node search process in surgically removed cancer tissues, improving reliability, reducing costs, and creating a new frontier in ex vivo tissue analysis.
TheraV (Wilmington, DE)
TheraV is a medtech company revolutionizing nerve pain recovery for amputees through its patented, drug-free vibration therapy.
Trevarx Biomedical, Inc.
(Philadelphia, PA)
Trevarx Biomedical is developing the first alpha radiopharmaceutical therapy to reach the nucleus — where cancer can't hide.
Cohort 9 Investors-in-Residence
- Shalanda Armstrong, Managing Partner, 100KM Ventures (Arlington, VA)
- John Chavez, Managing Director, New Mexico Start-Up Factory (Albuquerque, NM)
- Nate Kline, Managing General Partner, Cistern Capital (New York, NY)
- Greg Howard, General Partner, Quorum Capital Partners (Wilmington, DE)
- Justin Kang, General Partner, Visible Hands (Brooklyn, NY)
The Capital Readiness Program is funded in part through a Grant with the U.S. Small Business Administration and the U.S. Economic Development Administration (EDA).
The program is free to selected participants, and there is no pitch competition or demo-day— the focus is entirely on building investor-grade readiness and strategic maturity.
Applications are now open for 2026 cohorts:
- Cohort 10: March 2-6
- Cohort 11: April 27-May 1
- Cohort 12: December 7-11
Learn more and apply here: https://sciencecenter.org/programs/capital-readiness
About the Science Center
The Science Center is a premier catalyst of entrepreneurial activity, healthcare innovation, and economic growth. Recognized by The Brookings Institution as a top-tier investor, mentor, and economic development partner, the Science Center has supported hundreds of early- and growth-stage companies, driving a combined $7.8B in annual economic impact in Greater Philadelphia alone. Today, the organization works across the globe to accelerate the translation of health innovations into real-world solutions, while delivering nationally recognized STEM education to Philadelphia youth. For more information, visit sciencecenter.org.
